Trials / Active Not Recruiting
Active Not RecruitingNCT04931134
Treatment of Anxiety Disorders With Trigeminal Nerve Stimulation
Trigeminal Nerve Stimulation in Anxiety Disorders: a Randomized Controlled Trial
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Dr. Rafael Freire · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Primary objectives: The primary objective is to ascertain if trigeminal nerve stimulation is an effective treatment with high tolerability for patients with panic disorder, generalized anxiety disorder and social anxiety disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Trigeminal nerve stimulation - active | Active trigeminal nerve stimulation |
| DEVICE | Trigeminal nerve stimulation - sham | Sham trigeminal nerve stimulation |
Timeline
- Start date
- 2022-02-07
- Primary completion
- 2025-12-31
- Completion
- 2026-01-31
- First posted
- 2021-06-18
- Last updated
- 2025-04-08
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04931134. Inclusion in this directory is not an endorsement.